VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 175 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $197,000 | -43.6% | 10,192 | -25.6% | 0.08% | -38.5% |
| Q2 2022 | $349,000 | -12.8% | 13,692 | -11.9% | 0.12% | -1.6% |
| Q1 2022 | $400,000 | -30.6% | 15,542 | +13.0% | 0.12% | -17.9% |
| Q4 2021 | $576,000 | +10.3% | 13,752 | +14.7% | 0.15% | +6.3% |
| Q3 2021 | $522,000 | -7.6% | 11,992 | +0.4% | 0.14% | -11.2% |
| Q2 2021 | $565,000 | +1.4% | 11,942 | +9.8% | 0.16% | -6.4% |
| Q1 2021 | $557,000 | +17.3% | 10,872 | -38.8% | 0.17% | +14.8% |
| Q4 2020 | $475,000 | +13.1% | 17,752 | +45.1% | 0.15% | -3.2% |
| Q3 2020 | $420,000 | -6.2% | 12,232 | +11.9% | 0.15% | -13.0% |
| Q2 2020 | $448,000 | – | 10,932 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |